News

FlexTrade Releases Latest Q&A on Best Execution Platform

FlexTrade (@FlexTrade) today released their latest Q&A titled: ‘How will MiFID II impact FX execution for the buy-side?’.

The FlexTRADER EMS currently covers Spot FX and NDFs and other FX derivatives. Except for Spot FX, these are derivatives which are in-scope “financial instruments” in MiFID II.

In this latest Q&A, FlexTrade have partnered with the legal firm Simmons & Simmons to respond to commonly asked questions from buy-side users around FlexTrade’s MTF/OTF status.

You can request your copy of ‘How will MiFID II impact FX execution for the buy-side?’  from FlexTrade’s Best Execution Platform, which showcases FlexTrade’s comprehensive approach to trading during MiFID II.

FlexTrade will be at TradeTechFX next week from September 12-13. Visit us at Booth 2 to learn more about this topic and more.

 

Best Execution Platform

6
Sep